Pretraživanje
Prikaz rezultata 1-10 od 11
Consequences of angiotensin II type 1 receptor blockade on renal hemodynamic and morphology in adriamycin-induced nephropathy
(Lippincott Williams & Wilkins, Philadelphia, 2002)
Biochemical consequences of acute no blokade and ET-1 infusion in Wistar rats
(Lippincott Williams & Wilkins, Philadelphia, 2003)
Bosentan reduces blood pressure and improves kidney function and morphology in mild NO deficiency assotiated with experimental acute renal failure
(Lippincott Williams & Wilkins, Philadelphia, 2008)
Vit C decreases blood pressure, improves renal haemodynamics and reduces tubular dilatation in shr with postischemic acute renal failure (ARF)
(Lippincott Williams & Wilkins, Philadelphia, 2008)
Systemic haemodynamics and left ventricular hypertrophy in SHR with adriamycin nephropathy: Short term and long term effects of losartan treatment
(Lippincott Williams & Wilkins, Philadelphia, 2006)
L-arginine decreases mean arterial pressure and renal vascular resistance in SHR with induced postischemic acute renal failure
(Lippincott Williams & Wilkins, Philadelphia, 2006)
Resveratrol reduces blood pressure and systolic volume in SH rats
(Lippincott Williams & Wilkins, Philadelphia, 2008)
Effects of FeSOD on heamodynamic parameters and oxidative status in SH rats
(Lippincott Williams & Wilkins, Philadelphia, 2005)
Combined treatment with Losartan and L-arginine increase sod activity and improve haemodimanics and glomerular filtration in SHR
(Lippincott Williams & Wilkins, Philadelphia, 2008)
Comparative effects of L-arginine and losartan on hemodinamic parameters in SH rats
(Lippincott Williams & Wilkins, Philadelphia, 2006)